ACE2 and infection: The current treatment for COVID-19 is a bimodal therapy, one targets early infection and virus replication, and the other targets the systemic inflammatory phase of late infection and regulation [37], including host immune regulation, antiviral therapy, plasma therapy, anticoagulation therapy, ACE2 inhibitors, and steroid hormones.